SCHEMBL14568852

SCHEMBL14568852

CCCCCCC(=O)O[C@H]1CCC2C3CCC4=CC(=O)CCC4C3CC[C@@]21C

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 5/20 1.00
▸ LMNA P02545 5/20 1.00
▸ AR P10275 3/20 0.62
▸ SERPINA6 P08185 2/20 0.60
▸ ALDH1A1 P00352 2/20 0.60
▸ SLC22A1 O15245 1/20 0.60
▸ SHBG P04278 1/20 0.60
▸ THRB P10828 1/20 0.60
▸ MCL1 Q07820 1/20 0.56
▸ CYP1A2 P05177 1/20 0.56
▸ HIF1A Q16665 1/20 0.56
▸ HSD17B10 Q99714 1/20 0.56
▸ PGR P06401 3/20 0.53
▸ CYP3A4 P08684 3/20 0.53
▸ KMT2A Q03164 2/20 0.53
▸ ESR1 P03372 1/20 0.53
▸ POLB P06746 1/20 0.53
▸ ADORA3 P0DMS8 1/20 0.53
▸ CHRM1 P11229 1/20 0.53
▸ TBXA2R P21731 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Nandrolone Decanoate SCHEMBL6151508 1.00 MAPT (1.00) MAPTLMNAARSERPINA6ALDH1A1
Nandrolone Decanoate SCHEMBL19834508 1.00 MAPT (1.00) MAPTLMNAARSERPINA6ALDH1A1
SCHEMBL3803109 1.00 MAPT (1.00) MAPTLMNAARSERPINA6ALDH1A1
SCHEMBL635908 1.00 MAPT (1.00) MAPTLMNAARSERPINA6ALDH1A1
SCHEMBL11593159 1.00 MAPT (1.00) MAPTLMNAARSERPINA6ALDH1A1
Nandrolone Decanoate SCHEMBL16107220 1.00 MAPT (1.00) MAPTLMNAARSERPINA6ALDH1A1
SCHEMBL11351978 1.00 MAPT (1.00) MAPTLMNAARSERPINA6ALDH1A1
Nandrolone Decanoate SCHEMBL10710160 1.00 MAPT (1.00) MAPTLMNAARSERPINA6ALDH1A1
SCHEMBL3850364 1.00 MAPT (1.00) MAPTLMNAARSERPINA6ALDH1A1
Nandrolone Decanoate SCHEMBL30692744 1.00 MAPT (1.00) MAPTLMNAARSERPINA6ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7196074-B2 Methods of making, using and pharmaceutical formulations comprising 7α, 11β-dimethyl-17β-hydroxyestra-4, 14-dien-3-one and 17 esters thereof THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2007-03-27 — — US disclosed
Send feedback